The complex roles of neurosteroids in depression and anxiety disorders.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neurochemistry International

• Publication date

  2008-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.NEUINT.2007.10.001PMID 17996986
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroactive Steroids in Depression and Anxiety Disorders: Clinical Studies

  2007cited by this paper
• Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake

  2006cited by this paper
• Gas chromatography-mass spectrometry.

  2006cited by this paper
• Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder.

  2006cited by this paper
• The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease.

  2006cited by this paper
• Fluoxetine 40–60 mg versus Fluoxetine 20 mg in the Treatment of Children and Adolescents with a Less-Than-Complete Response to Nine-Week Treatment with Fluoxetine 10–20 mg: APilot Study

  2006cited by this paper
• Comparative non-radioactive RT-PCR assay: an approach to study the neurosteroids biosynthetic pathway in humans.

  2006cited by this paper
• Evaluating the comparability of gene expression in blood and brain

  2006cited by this paper
• Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3α-hydroxysteroid dehydrogenase activity

  2006cited by this paper
• Neurosteroids, neuroactive steroids, and symptoms of affective disorders.

  2006cited by this paper
• Plasma Concentrations of Neuroactive Steroids before and after Electroconvulsive Therapy in Major Depression

  2005cited by this paper
• Neuroactive steroids and suicidality in posttraumatic stress disorder.

  2005cited by this paper
• Panic Induction with Cholecystokinin-Tetrapeptide (CCK-4) Increases Plasma Concentrations of the Neuroactive Steroid 3α, 5α Tetrahydrodeoxycorticosterone (3α, 5α-THDOC) in Healthy Volunteers

  2005cited by this paper
• Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder.

  2005cited by this paper
• Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers.

  2005cited by this paper
• Lymphocytes as a neural probe: potential for studying psychiatric disorders.

  2004cited by this paper
• An Increased Capacity for Adrenal DHEA Release is Associated with Decreased Avoidance and Negative Mood Symptoms in Women with PTSD

  2004cited by this paper
• Neuroactive steroids are not affected by panic induction with 50 microg cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers.

  2004cited by this paper
• Plasma Concentrations of Anxiolytic Neurosteroids in Men with Normal Anxiety Scores: A Correlation Analysis

  2004cited by this paper
• Changes in cortisol and dehydroepiandrosterone in women victims of physical and psychological intimate partner violence.

  2004cited by this paper
• Effect of medical comorbidity on response to fluoxetine augmentation or dose increase in outpatients with treatment-resistant depression.

  2004cited by this paper
• Neuroactive steroid levels in patients with panic disorder.

  2003cited by this paper
• Neurosteroid secretion in panic disorder.

  2003cited by this paper
• Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia.

  2003cited by this paper
• Effects of Alprazolam on Cholecystokinin-Tetrapeptide-Induced Panic and Hypothalamic–Pituitary–Adrenal-Axis Activity: A Placebo-Controlled Study

  2003cited by this paper
• Steroid hormones and neurosteroids in normal and pathological aging of the nervous system.

  2003cited by this paper
• Neuroactive steroid levels in patients with panic disorder.

  2003cited by this paper
• Depression in Parkinson's disease: clinical correlates and outcome.

  2003cited by this paper
• Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results.

  2003cited by this paper
• Decreased plasma and cerebrospinal fluid content of neuroactive steroids in Parkinson’s disease

  2003cited by this paper
• Neurosteroid modulation of GABAA receptors.

  2003cited by this paper
• Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrin.

  2002cited by this paper
• Neurosteroids in depression: a review

  2002cited by this paper
• Influence of Sleep Deprivation on Neuroactive Steroids in Major Depression

  2002cited by this paper
• Plasma Concentrations of Neuroactive Steroids before and after Repetitive Transcranial Magnetic Stimulation (rTMS) in Major Depression

  2002cited by this paper
• Elevated Blood Levels of Dehydroepiandrosterone Sulphate Vary with Symptom Load in Posttraumatic Stress Disorder: Findings from a Longitudinal Study of Refugees in Sweden

  2002cited by this paper
• Low pregnenolone sulphate plasma concentrations in patients with generalized social phobia

  2002cited by this paper
• Molecular targets in the treatment of anxiety.

  2002cited by this paper
• GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment.

  2002cited by this paper
• Neurosteroids: beginning of the story.

  2001cited by this paper
• The socially-isolated mouse: a model to study the putative role of allopregnanolone and 5alpha-dihydroprogesterone in psychiatric disorders.

  2001cited by this paper
• Neuroactive steroids in neuropsychopharmacology.

  2001cited by this paper
• Allopregnanolone assays.

  2001cited by this paper
• Neuroactive steroid levels in patients with generalized anxiety disorder.

  2001cited by this paper
• Neurosteroid analysis.

  2001cited by this paper
• Defective cortisone 11-oxoreductase activity?

  2001cited by this paper
• How much "UFC" is really cortisol?

  2000cited by this paper
• Determination of progesterone and some of its neuroactive ring A-reduced metabolites in human serum.

  2000cited by this paper
• Neurosteroids: biosynthesis and function of these novel neuromodulators.

  2000cited by this paper
• Elevated circulatory level of GABAA – antagonistic neurosteroids in patients with combat-related post-traumatic stress disorder

  2000cited by this paper
• Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives.

  1999cited by this paper
• Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3α, 5α- tetrahydroprogesterone (allopregnanolone) availability?

  1998cited by this paper
• Effects of antidepressant treatment on neuroactive steroids in major depression.

  1998cited by this paper
• Prominent sex steroid metabolism in human lymphocytes.

  1998cited by this paper
• Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3 alpha, 5 alpha-tetrahydroprogesterone (allopregnanolone) availability?

  1998cited by this paper
• Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine.

  1998cited by this paper
• Metabolism of progesterone by human lymphocytes: production of neuroactive steroids.

  1997cited by this paper
• Use of low-dose fluoxetine in major depression and panic disorder.

  1993cited by this paper

• Neurosteroids, Anxiety and Quality of Life in Acromegaly

  2025cites this paper
• Role of allopregnanolone-mediated γ-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development

  2023cites this paper
• Changes in neuroactive steroids, neurotrophins and immunological biomarkers after monotherapy 8-week rTMS treatment and their relationship with neurocognitive functions in depression

  2023cites this paper
• Relating neurosteroid modulation of inhibitory neurotransmission to behaviour

  2021cites this paper
• Shaping of the Female Human Brain by Sex Hormones: A Review

  2020cites this paper
• The intersections of stress, anxiety and epilepsy.

  2020cites this paper
• Neurosteroids and Affective Disorders in Women

  2019cites this paper
• L-3,3’,5-triiodothyronine and pregnenolone sulfate inhibit Torpedo nicotinic acetylcholine receptors

  2019cites this paper
• Stress and drug abuse-related disorders: the promising therapeutic value of neurosteroids Focus on Pregnenolone-Progesterone-Allopregnanolone pathway.

  2019cites this paper
• Neuroactive Steroids and GABAergic Involvement in the Neuroendocrine Dysfunction Associated With Major Depressive Disorder and Postpartum Depression

  2019cites this paper
• Neuroesteroides e esquizofrenia: a função do estrogênio e da progesterona na modulação e proteção do cérebro

  2019cites this paper
• Afastamento do trabalho por depressão em docentes da rede pública

  2019cites this paper
• How can methylprednisolone work on epileptic spasms with malformation of cortical development?

  2019cites this paper
• Neurosteroids: non‐genomic pathways in neuroplasticity and involvement in neurological diseases

  2018cites this paper
• Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications

  2018cites this paper
• The neuroprotective effect of focused ultrasound: New perspectives on an old tool.

  2017cites this paper
• Essential Tremor is not Only a Movement Disorder; Its Relationship with Sleep and Anxiety.

  2017cites this paper
• The Brain Protective Effect of rTMS (Repetitive Transcranial Magnetic Stimulation) in Depression: A Mini-Review in Animal Studies.

  2016cites this paper
• Neurosteroids; potential underpinning roles in maintaining homeostasis.

  2016cites this paper
• GABAA receptor-acting neurosteroids: A role in the development and regulation of the stress response

  2015cites this paper
• Developmentally regulated neurosteroid synthesis enhances GABAergic neurotransmission in mouse thalamocortical neurones

  2015cites this paper
• Cycles of risk: Associations between menstrual cycle and suicidal ideation among women

  2015cites this paper
• The effect of early–life exposure of rats to venlafaxine on behaviour and neurological markers of antidepressant action in adulthood

  2014cites this paper
• The combination of metyrapone and oxazepam for the treatment of cocaine and other drug addictions.

  2014cites this paper
• Pregnenolone sulphate enhances spatial orientation and object discrimination in adult male rats: evidence from a behavioural and electrophysiological study.

  2014cites this paper
• 5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann’s area 9 (BA9) of depressed patients

  2014cites this paper
• Prevalence, Incidence, and Persistence of Psychiatric and Substance Use Disorders Among Mothers Living With HIV

  2014cites this paper
• The role of pregnenolone sulphate in spatial orientation-acquisition and retention: an interplay between cognitive potentiation and mood regulation.

  2013cites this paper
• The involvement of noradrenergic mechanisms in the suppressive effects of diazepam on the hypothalamic-pituitary-adrenal axis activity in female rats

  2012cites this paper
• Abnormal Hippocampal BDNF and miR-16 Expression Is Associated with Depression-Like Behaviors Induced by Stress during Early Life

  2012cites this paper
• Decreased plasma brain-derived neurotrophic factor levels in institutionalized elderly with depressive disorder.

  2012cites this paper
• Biosafety of multiwalled carbon nanotube in mice: a behavioral toxicological approach.

  2012cites this paper
• Brain energy metabolism is increased by chronic administration of bupropion

  2012cites this paper
• Differential effects of escitalopram administration on metabolic parameters of cortical and subcortical brain regions of Wistar rats

  2012cites this paper
• Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis.

  2011cites this paper
• A mutant residue in the third transmembrane region of the GABA(A) alpha1 subunit causes increased agonistic neurosteroid responses.

  2011cites this paper
• Beyond the HPA Axis: Progesterone-Derived Neuroactive Steroids in Human Stress and Emotion

  2011cites this paper
• Pathobiological targets of depression

  2011cites this paper
• The antidepressant-like effect of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane involves a regulation of β-type estrogen receptors

  2011cites this paper
• Neurosteroids and GABAA Receptor Interactions: A Focus on Stress

  2011cites this paper
• Discovering imaging endophenotypes for major depression

  2011cites this paper
• Dynamic proteomic analysis of protein expression profiles in whole brain of Balb/C mice subjected to unpredictable chronic mild stress: implications for depressive disorders and future therapies.

  2011cites this paper
• The effect of early-life exposure of stress-sensitive rats to the serotonin-norepinephrine reuptake inhibitor Vanlafaxine on behaviour in adulthood

  2011cites this paper
• In a mouse model relevant for post-traumatic stress disorder, selective brain steroidogenic stimulants (SBSS) improve behavioral deficits by normalizing allopregnanolone biosynthesis

  2010cites this paper
• The effects of acute, chronic and withdrawn progesterone in male and female Mongolian gerbils (Meriones unguiculatus) in two tests of anxiety.

  2010cites this paper
• Antidepressant-like effects of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).

  2010cites this paper
• The pharmacology of anxiety.

  2010cites this paper
• Association of the GABRD gene and childhood‐onset mood disorders

  2010cites this paper
• Evaluation of Krebs cycle enzymes in the brain of rats after chronic administration of antidepressants.

  2010cites this paper
• The Journal of Toxicological Sciences

  2010cites this paper
• Utilisation du trilostane pour le traitement de la depression

  2009cites this paper
• The effects of neuroactive steroids on acute ethanol withdrawl in mice

  2009cites this paper
• Steroid hormone fluctuations and GABA(A)R plasticity.

  2009cites this paper
• Brain creatine kinase activity is increased by chronic administration of paroxetine.

  2009cites this paper
• Acute administration of ketamine reverses the inhibition of mitochondrial respiratory chain induced by chronic mild stress.

  2009cites this paper
• Dehydroepiandrosterone formation is independent of cytochrome P450 17alpha-hydroxylase/17, 20 lyase activity in the mouse brain.

  2009cites this paper
• Brain-derived neurotrophic factor, stress and depression: a minireview.

  2009cites this paper
• A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system.

  2009cites this paper
• The anxiolytic etifoxine protects against convulsant and anxiogenic aspects of the alcohol withdrawal syndrome in mice.

  2009cites this paper
• A reproductive subtype of depression: conceptualizing models and moving toward etiology.

  2009cites this paper
• Inhibitory effect of antidepressants on the NMDA-evoked [(3)H]noradrenaline release from rat hippocampal slices.

  2009cites this paper
• Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression.

  2008cites this paper
• Using trilistane for the treatment of depression

  2008cites this paper
• GABA(A)R plasticity during pregnancy: relevance to postpartum depression.

  2008cites this paper
• Neurosteroid Biosynthesis Regulates Sexually Dimorphic Fear and Aggressive Behavior in Mice

  2008cites this paper
• ATIVIDADE DA CREATINA QUINASE CEREBRAL É AUMENTADA PELA ADMINISTRAÇÃO CRÔNICA DE PAROXETINA

  year unknowncites this paper